The White House gave the Food and Drug Administration (FDA) an ultimatum to officially approve an emergency use authorization (EUA) today for the Pfizer-BioNTech COVID-19 vaccine, a day after the agency's advisory panel recommended approval, and with a separate decision still needed from a Centers for Disease Control and Prevention (CDC) panel.The pressure over the EUA approval raises worries that the process has been rushed, which could feed into people's doubts about the vaccine.
Vaccine decisions also come amid what could be the start of the feared post-Thanksgiving surge of illnesses and deaths.And as the first vaccine sails through EUA approval in the United States and a few other countries, two vaccines that are in development hit